158 related articles for article (PubMed ID: 31961476)
21. Cystoprostatectomy versus prostatectomy alone for locally advanced or recurrent pelvic cancer.
Turner GA; Harris CA; Eglinton TW; Wakeman CJ; Kueppers F; Dixon L; Dobbs BR; Frizelle FA
ANZ J Surg; 2016; 86(1-2):54-8. PubMed ID: 25113257
[TBL] [Abstract][Full Text] [Related]
22. Extended pelvic resections for recurrent uterine and cervical cancer: out-of-the-box surgery.
Caceres A; Mourton SM; Bochner BH; Gerst SR; Liu L; Alektiar KM; Kardos SV; Barakat RR; Boland PJ; Chi DS
Int J Gynecol Cancer; 2008; 18(5):1139-44. PubMed ID: 18053063
[TBL] [Abstract][Full Text] [Related]
23. Feasibility of transanal minimally invasive surgery for total pelvic exenteration for advanced primary and recurrent pelvic malignancies.
Beppu N; Ito K; Otani M; Imada A; Matsubara T; Song J; Kimura K; Kataoka K; Kuwahara R; Horio Y; Uchino M; Ikeuchi H; Ikeda M
Tech Coloproctol; 2023 Dec; 27(12):1367-1375. PubMed ID: 37878167
[TBL] [Abstract][Full Text] [Related]
24. Clinical algorithm for the management of advanced pelvic tumours involving the aortoiliac axis.
Rajendran S; Nguyen CL; Brown KGM; Solomon MJ
Eur J Surg Oncol; 2023 Jul; 49(7):1317-1319. PubMed ID: 36964055
[TBL] [Abstract][Full Text] [Related]
25. Outcomes following repeat exenteration for locally advanced pelvic malignancy.
Blake J; Koh CE; Steffens D; De Robles MS; Brown K; Lee P; Austin K; Solomon MJ
Colorectal Dis; 2021 Mar; 23(3):646-652. PubMed ID: 33058495
[TBL] [Abstract][Full Text] [Related]
26. Predictors of overall survival following extended radical resections for locally advanced and recurrent pelvic malignancies.
Kong JC; Peacock O; Waters PS; Eglinton T; Warrier SK; Wakeman C; Frizelle FA; Heriot AG; McCormick JJ
Langenbecks Arch Surg; 2020 Jun; 405(4):491-502. PubMed ID: 32533361
[TBL] [Abstract][Full Text] [Related]
27. Pelvic exenteration for recurrent gynecologic malignancy: a study of 28 consecutive patients at a single institution.
Jäger L; Nilsson PJ; Rådestad AF
Int J Gynecol Cancer; 2013 May; 23(4):755-62. PubMed ID: 23407096
[TBL] [Abstract][Full Text] [Related]
28. Extended sacropelvic resection for locally recurrent rectal cancer: can it be done safely and with good oncologic outcomes?
Colibaseanu DT; Dozois EJ; Mathis KL; Rose PS; Ugarte ML; Abdelsattar ZM; Williams MD; Larson DW
Dis Colon Rectum; 2014 Jan; 57(1):47-55. PubMed ID: 24316945
[TBL] [Abstract][Full Text] [Related]
29. Laterally Extended Pelvic Resection for Gynaecological Malignancies: A Multicentric Experience with Out-of-the-Box Surgery.
Vizzielli G; Naik R; Dostalek L; Bizzarri N; Kucukmetin A; Tinelli G; Scambia G; Cibula D
Ann Surg Oncol; 2019 Feb; 26(2):523-530. PubMed ID: 30539489
[TBL] [Abstract][Full Text] [Related]
30. Pelvic exenteration for advanced and recurrent malignancy.
Zoucas E; Frederiksen S; Lydrup ML; Månsson W; Gustafson P; Alberius P
World J Surg; 2010 Sep; 34(9):2177-84. PubMed ID: 20512493
[TBL] [Abstract][Full Text] [Related]
31. Changing outcomes following pelvic exenteration for locally advanced and recurrent rectal cancer.
PelvEx Collaborative
BJS Open; 2019 Aug; 3(4):516-520. PubMed ID: 31388644
[TBL] [Abstract][Full Text] [Related]
32. Pushing the boundaries of pelvic exenteration by maintaining survival at the cost of morbidity.
Venchiarutti RL; Solomon MJ; Koh CE; Young JM; Steffens D
Br J Surg; 2019 Sep; 106(10):1393-1403. PubMed ID: 31282571
[TBL] [Abstract][Full Text] [Related]
33. [Results of laparoscopic pelvic exenterations].
Sanzharov AE; Gallyamov EA; Sergeev VP; Biktimirov RG; Aminova LN; Kochkin AD; Meshchankin IV; Agapov MA; Gololobov GY
Khirurgiia (Mosk); 2022; (7):45-57. PubMed ID: 35775844
[TBL] [Abstract][Full Text] [Related]
34. Extended pelvic resections for recurrent or persistent uterine and cervical malignancies: an update on out of the box surgery.
Andikyan V; Khoury-Collado F; Sonoda Y; Gerst SR; Alektiar KM; Sandhu JS; Bochner BH; Barakat RR; Boland PJ; Chi DS
Gynecol Oncol; 2012 May; 125(2):404-8. PubMed ID: 22285844
[TBL] [Abstract][Full Text] [Related]
35. [Robot-assisted laparoscopy in the management of recurrent pelvic cancer].
Jauffret C; Lambaudie E; Bannier M; Buttarelli M; Houvenaeghel G
Gynecol Obstet Fertil; 2011 Dec; 39(12):674-80. PubMed ID: 21871833
[TBL] [Abstract][Full Text] [Related]
36. Assessing the impact of a sacral resection on morbidity and survival after extended radical surgery for locally recurrent rectal cancer.
Milne T; Solomon MJ; Lee P; Young JM; Stalley P; Harrison JD
Ann Surg; 2013 Dec; 258(6):1007-13. PubMed ID: 23364701
[TBL] [Abstract][Full Text] [Related]
37. Total pelvic exenteration for the treatment of advanced primary or recurrent pelvic neoplasia.
Carballo L; Enríquez-Navascués JM; Saralegui Y; Placer C; Timoteo A; Borda N; Carrillo A; Sainz-Lete A
Cir Esp; 2015 Mar; 93(3):174-80. PubMed ID: 25443154
[TBL] [Abstract][Full Text] [Related]
38. The Price We Pay for Radical Curative Pelvic Exenterations: Prevalence and Management of Pain.
Lim JS; Koh CE; Liu H; Solomon MJ; Johnstone CSH
Dis Colon Rectum; 2018 Mar; 61(3):314-319. PubMed ID: 29420427
[TBL] [Abstract][Full Text] [Related]
39. Extended lateral pelvic sidewall excision (ELSiE): an approach to optimize complete resection rates in locally advanced or recurrent anorectal cancer involving the pelvic sidewall.
Shaikh I; Aston W; Hellawell G; Ross D; Littler S; Burling D; Marshall M; Northover JM; Antoniou A; Jenkins JT
Tech Coloproctol; 2014 Dec; 18(12):1161-8. PubMed ID: 25380742
[TBL] [Abstract][Full Text] [Related]
40. Outcomes of extended total mesorectal excision in patients with locally advanced rectal cancer.
Saravanabavan S; Kazi M; Murugan J; Vispute T; Vijayakumaran P; Desouza A; Saklani A
Colorectal Dis; 2023 Jul; 25(7):1423-1432. PubMed ID: 37246309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
